{"disease":{"id":"streptococcal-infections","name":"streptococcal infections"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04841369","title":"Phase III Clinical Trial of a Candidate PCV13 in Healthy People Aged 6 Weeks and Above (PICTPCV13i)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":3420,"lead_sponsor_name":"CanSino Biologics Inc.","has_results":false},{"nct_id":"NCT02270944","title":"Safety and Immunogenicity of the Liquid Formulation of Group B Streptococcus Trivalent Vaccine and of the Lyophilized Formulation of Group B Streptococcus Trivalent Vaccine","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":1053,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT07017777","title":"A Study to Evaluate the Immunogenicity and Safety of 13-valent Pneumococcal Conjugate Vaccine (PCV13i) in Healthy Infants Aged 2 Months (Minimum 6 Weeks)","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":600,"lead_sponsor_name":"CanSino Biologics Inc.","has_results":false},{"nct_id":"NCT03055728","title":"Rapid Strep Testing in Children With Recent Streptococcal Pharyngitis","phase":"","overall_status":"COMPLETED","enrollment_count":600,"lead_sponsor_name":"Georgetown University","has_results":false},{"nct_id":"NCT03170609","title":"A Phase 1/2, Randomized, Placebo-controlled, Observer-blinded Trial To Evaluate The Safety, Tolerability, And Immunogenicity Of A Multivalent Group B Streptococcus Vaccine In Healthy Adults 18 To 49 Years Of Age","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":365,"lead_sponsor_name":"Pfizer","has_results":true},{"nct_id":"NCT04100772","title":"Phase I Clinical Trial of a Candidate PCV13 in Healthy People Aged 6 Weeks and Above","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":237,"lead_sponsor_name":"CanSino Biologics Inc.","has_results":false},{"nct_id":"NCT06473506","title":"Group A Streptococcus Saliva Study","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":200,"lead_sponsor_name":"The Hospital for Sick Children","has_results":false},{"nct_id":"NCT04258995","title":"A TRIAL TO EVALUATE THE SAFETY, TOLERABILITY, AND IMMUNOGENICITY OF A BOOSTER DOSE OF A GROUP B STREPTOCOCCUS 6 VALENT POLYSACCHARIDE CONJUGATE VACCINE (GBS6) IN HEALTHY ADULTS","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":151,"lead_sponsor_name":"Pfizer","has_results":true},{"nct_id":"NCT05726006","title":"Invasive Group B Streptococcus Disease Burden and Its Antimicrobial Resistance in Malaysia Among Non-pregnant Adults.","phase":"","overall_status":"UNKNOWN","enrollment_count":133,"lead_sponsor_name":"Universiti Putra Malaysia","has_results":false},{"nct_id":"NCT07085702","title":"A Study to Evaluate Safety, Reactogenicity, and Immunogenicity of the GSK 4-component Strep A Vaccine With Aluminum Hydroxide (Alum) or AS37 in Healthy Young Adults","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":108,"lead_sponsor_name":"GlaxoSmithKline","has_results":false},{"nct_id":"NCT05782179","title":"Study to Evaluate the Safety, Tolerability and Immunogenicity of Three Doses of GBS Vaccine in Elderly Participants","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":90,"lead_sponsor_name":"Minervax ApS","has_results":true},{"nct_id":"NCT06818656","title":"The Unhide™ Project: Economic Impact Study of IVIG Treatment for PANS","phase":"","overall_status":"COMPLETED","enrollment_count":65,"lead_sponsor_name":"Brain Inflammation Collaborative","has_results":false},{"nct_id":"NCT03361163","title":"Controlled Human Infection for Vaccination Against Streptococcus Pyogenes","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":25,"lead_sponsor_name":"Andrew Steer","has_results":false}],"total":13},"guidelines":[],"source":"Drug Landscape verified database"}